Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Key Inclusion Criteria:~* Previously randomized to R475-PN-1523 (NCT02683239), R475-OA-1611 (NCT03161093), or R475-OA-1688 (NCT03304379) and received at least 1 dose of study drug~* Notified the site that they are planning a knee or hip arthroplasty during the parent study between randomization and 24 weeks after the last dose of subcutaneous (SC) study drug~* Patient's surgeon/pathologist is willing to coordinate with the site regarding preparation, storage, and shipping of joint tissue samples collected during arthroplasty surgery~Exclusion Criteria:~* None~Note: Other protocol Inclusion criteria apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Knee or Hip Joint Arthroplasty (Type: OTHER): Patients with OA of the knee or hip who are participating in an ongoing fasinumab phase 3 parent study

Based on this trial design, predict the completion outcome and termination type (if applicable).